- Following the Cass report, the NHS published new guidelines for treating trans-identifying youth, abandoning its previous endorsement of the “gender-affirming” model of care for a more cautious approach.
- The NHS now recognizes that children and adolescents identifying as transgender may be experiencing a “transient phase” and has banned the use of puberty blockers in patients under 18, making exceptions only in certain cases for strict clinical trials.
- The new guidelines “reflect evidence that in most cases gender incongruence does not persist into adolescence” for young children.
